TAIMEZHAKI PARKER: Open Payments
NPI 1659767549 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 18 payments from 13 companies in 2025. Trend: 2023 $317 · 2024 $543 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $72 |
| PFIZER INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Kite Pharma, Inc. | 1 | $34 |
| SOBI, INC | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
Products named: Lenvima, ENHERTU, Yescarta, Doptelet, SARCLISA, MONOFERRIC, KEYTRUDA, LIBTAYO.
Industry payments across OK — which companies pay providers there.
